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Abstract
Mutations in the CRB1 gene are associated with variable phenotypes of severe retinal dystrophies,
ranging from Leber Congenital Amaurosis (LCA) to rod-cone dystrophy (also called retinitis
pigmentosa (RP)). Moreover, retinal dystrophies resulting from CRB1 mutations may be
accompanied by specific fundus features: preservation of the para-arteriolar retinal pigment
epithelium (PPRPE) and retinal telangiectasia with exudation (also referred to as Coats-like
vasculopathy). In this publication we report seven novel mutations and classify over 150 reported
CRB1 sequence variants that were found in more that 240 patients. The data from previous reports
was used to analyse a potential correlation between CRB1 variants and the clinical features of
respective patients. This meta-analysis suggests that the differential phenotype of patients with
CRB1 mutations is due to additional modifying factors rather than particular mutant allele
combination.
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Background
Mutations in the CRB1 gene (MIM# 604210) are associated with variable phenotypes of
severe retinal dystrophies, ranging from Leber Congenital Amaurosis (LCA) to rod-cone
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dystrophy (also called retinitis pigmentosa (RP)) (Azam, et al., 2011; Benayoun, et al., 2009;
Bernal, et al., 2003; Booij, et al., 2005; Clark, et al., 2010; Coppieters, et al., 2010; den
Hollander, et al., 2004; den Hollander, et al., 2001a; den Hollander, et al., 2007; den
Hollander, et al., 1999; Galvin, et al., 2005; Gerber, et al., 2002; Hanein, et al., 2004;
Henderson, et al., 2010; Henderson, et al., 2007; Jacobson, et al., 2003; Khaliq, et al., 2003;
Li, et al., 2011; Lotery, et al., 2001a; Lotery, et al., 2001b; Riveiro-Alvarez, et al., 2008;
Seong, et al., 2008; Siemiatkowska, et al., 2011; Simonelli, et al., 2007; Tosi, et al., 2009;
Vallespin, et al., 2007; Walia, et al., 2010; Yzer, et al., 2006a; Yzer, et al., 2006b; Zernant,
et al., 2005). LCA is a group of the most severe and the earliest occurring retinal dystrophies
resulting in congenital blindness (den Hollander, et al., 2008). The onset of the disease
occurs at birth and the characteristic features include non-recordable electroretinogram
(ERG), nystagmus, sluggish or absent pupillary responses and oculo-digital reflexes, a
distinctive eye-rubbing also called the Franschetti sign (den Hollander, et al., 2008;
Franceschetti and Dieterle, 1954; Leber, 1869). RP is a clinically heterogeneous disorder
characterised by a progressive degeneration of the photoreceptors and leading to a visual
impairment of variable severity that can end in complete blindness. The disease onset is
highly variable: it may commence in the first decade of life or much later. There is a
considerable clinical overlap between LCA and early-onset RP and in some cases/reports the
diagnosis is ambiguous. Early-onset RP, however, is considered as a relatively milder form,
where patients do not have a congenital onset of visual impairment.
LCA and RP resulting from CRB1 mutations may be accompanied by specific fundus
features: preservation of the para-arteriolar retinal pigment epithelium (PPRPE) (Bernal, et
al., 2003; den Hollander, et al., 2004; den Hollander, et al., 1999; Heckenlively, 1982;
Henderson, et al., 2010; Khaliq, et al., 2003; Simonelli, et al., 2007; Yzer, et al., 2006b) and
retinal telangiectasia with exudation (also referred to as Coats-like vasculopathy)
(Coppieters, et al., 2010; den Hollander, et al., 2004; den Hollander, et al., 2001a;
Henderson, et al., 2010; Yzer, et al., 2006b). PPRPE is characterized by a relative
preservation of retinal pigment epithelium (RPE) adjacent to retinal arterioles despite a
panretinal RPE degeneration (Heckenlively, 1982). This is, however, not consistent in
CRB1-associated RP and the absence of PPRPE in a severe RP should not exclude CRB1 as
a potential causal gene (Lotery, et al., 2001b). Retinal telangiectasia is a condition of
abnormally permeable blood vessels, leading to exudation and retinal detachment (Cahill, et
al., 2001). Some patients with CRB1 mutations show macular atrophy (Henderson, et al.,
2010), similar features were found for other LCA causing genes (GUCY2D MIM# 600179,
AIPL1 MIM# 604392 and RPGRIP1 MIM# 605446), which lead to classification of LCA
into cone-rod LCA and rod-cone LCA (Hanein, et al., 2004). Patients with CRB1 mutations
belong to both categories. Predisposition of the CRB1 patients to keratoconus (McKibbin, et
al., 2010; McMahon, et al., 2009) and implication for pigmented paravenous chorioretinal
atrophy (McKay, et al., 2005) and nanophthalmos (Zenteno, et al., 2011) have also been
reported.
CRB1 is a human homologue of the Drosophila melanogaster gene coding for protein
crumbs (crb) and it is expressed in the retina and the brain (den Hollander, et al., 1999).
CRB1 consists of 12 exons and exhibits alternative splicing at the 3′ end, yielding two
proteins of 1376 and 1406 amino acids (den Hollander, et al., 2001b). Both proteins contain
19 epidermal growth factor (EGF)-like domains, three laminin A globular (AG)-like
domains and a signal peptide sequence. In addition, the longer isoform contains
transmembrane and cytoplasmic domains (den Hollander, et al., 2001b; Gosens, et al.,
2008). The cytoplasmic domain includes conserved FERM and PDZ binding motifs, through
which CRB1 participates in the formation of adherens junction and links to the actin
cytoskeleton (Gosens, et al., 2008).
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In Drosophila, crb determines the polarity of the embryonic epithelium and peripheral
neurons; it is important for the maintenance of zonula adherens (ZA) and it is localized in
the apical membrane (Tepass, et al., 1990). In the mouse retina, Crb1 is present in the apical
membranes of the epithelial cells, in Muller cells and in photoreceptor inner segments,
where it concentrates in the vicinity of the outer limiting membrane (den Hollander, et al.,
2002; Mehalow, et al., 2003; Pellikka, et al., 2002; van de Pavert, et al., 2004). A similar
distribution was found in the human retina (van de Pavert, et al., 2004). Crumbs and its
mouse homolog Crb1 is involved in the photoreceptor morphogenesis (Pellikka, et al., 2002;
Tepass, et al., 1990). Analysis of the naturally occurring Crb1rd8 mouse mutant, suggests a
developmental defect of the retina, where disruption of the outer limiting membrane and
formation of retinal folds (pseudorosettes) are observed (Mehalow, et al., 2003).
Disorganization of the retinal layers was also noted in other Crb1 mouse models (van de
Pavert, et al., 2004; van de Pavert, et al., 2007). These findings are in accordance with
clinical features of the patients carrying CRB1 mutations, whose retinas are thickened and
show an altered laminar organization, resembling an immature normal retina (Jacobson, et
al., 2003). The latter further supports the importance of CRB1 in the development of the
retina.
This study presents an overview of the previously published CRB1 variants and novel
mutations identified in a French cohort of simplex and autosomal recessive RP (arRP)
patients. Based on the available genetic and phenotypic data from the literature and on our
original findings, we classify all variants into one of the three groups (likely pathogenic,
unclassified variants and unlikely pathogenic, Supp. Tables S1-S3). We discuss the clinical
variability of patients harboring CRB1 mutations and analyse the phenotype-genotype
correlation of likely pathogenic changes. Identification of novel mutations in the French
cohort is described (Supp. Methods and Results) and precise clinical characterisation is
given.
Novel CRB1 Variants
Eleven unrelated patients with ar or isolated RP in the French cohort carried likely
pathogenic variants of CRB1 (Table 1). Seven mutations were novel: three missense changes
(p.Ser740Phe, p.Tyr1198Cys and p.Cys1223Ser), one nonsense mutation (p.Cys423*), one
in-frame deletion (p.Asn789del) and two frameshift deletions (p.Leu655Trpfs*10,
p.Ser1220Asnfs*62) (Table 1). Mutations identified in this study were not present in the
SNP databases nor listed as non-pathogenic variants in the literature. None of the novel
mutations was present in at least 362 control alleles and the mutations co-segregated in
available family members (Supp. Figure S1). In all but one patient (547) two mutated CRB1
alleles were found.
The three novel missense mutations are in the conserved domains of the CRB1 protein. The
p.Ser740Phe exchange replaces a highly conserved serine in the second laminin AG-like
domain, the p.Tyr1198Cys mutation replaces a conserved tyrosine with a cysteine in the 16th
calcium binding EGF-like domain and the p.Cys1223Ser is a replacement of a conserved
cysteine with a serine in the 17th calcium binding EGF-like domain (Figure 1). The in-frame
deletion p.Asn789del is also located in the second laminin AG-like domain. Other novel
mutations (p.Cys423*, p.Leu655Trpfs*10, p.Ser1220Asnfs*62) result in premature stop
codons, which most likely lead to nonsense mediated decay (Chang, et al., 2007) and
therefore these alleles are considered as null alleles. Five novel mutations are within exons 7
and 9, which are the most frequently mutated (Figure 1).
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Clinical Characterisation of Patients with CRB1 Mutations
Clinical findings of French patients with CRB1 mutations are summarized in Tables 2 and 3.
The average age at time of diagnosis was 17. Visual acuity was decreased in all patients
ranging from 20/50 to light perception with no clear correlation with age or duration of the
disease. Hyperopia was noted for 6/11 patients including three for whom spherical
equivalent was equal or above +5 diopters. Night blindness was present in all patients but
three, for whom a decrease of central vision and photophobia dominated. None of the
patients had nystagmus. Most patients (9/11) had a clear lens; in the remaining two, one had
undergone cataract surgery and one had significant lens opacities. These two patients were
over 40 years of age. Two patterns of fundus pigmentary changes were present in this
cohort: 7/11 had typical bone spicule-shaped pigment migration within the peripheral retina
whereas 4/11 had widespread clumped pigmentary changes of nummular appearance at the
level of the retinal pigment epithelium (Figure 2). Clumped pigmentation is therefore highly
suggestive of CRB1 mutations but it is not specific since it has also been associated with
mutations in NR2E3 (Schorderet and Escher, 2009; Sharon, et al., 2003), NRL (Nishiguchi,
et al., 2004) or TULP1 (Mataftsi, et al., 2007). None of the patients displayed preservation of
the para-arteriolar retinal pigment epithelium as previously described in association with
CRB1 mutations (Bernal, et al., 2003; den Hollander, et al., 2004; den Hollander, et al.,
1999; Heckenlively, 1982; Henderson, et al., 2010; Khaliq, et al., 2003; Simonelli, et al.,
2007; Yzer, et al., 2006b). In addition, none of the patients displayed Coats-like changes in
the periphery. All patients had macular involvement. Six of the patients displayed cystoid
macular edema whereas the other five had macular thinning with loss of the outer retinal
layers and corresponding loss of autofluorescence (Figure 2). Color vision was normal in
four patients or showed either tritan deficit or a dyschromatopsia with no clear axis when
visual acuity allowed color vision testing. Full field electroretinogram showed severe
generalized retinal dysfunction with no detectable responses in all patients except three for
whom some residual rod and cone function was detectable. Among those three, the best
responses on ERG were obtained in the youngest patients. Residual responses on ERG were
correlated with better preservation of the visual field.
All patients displayed severe retinal involvement with early macular changes, half of them
had cystoid macular edema, a higher percentage than the usually reported prevalence of
about 30% in overall RP (Hajali, et al., 2008). This higher prevalence could at least be in
part related to vascular abnormalities with Coats-like changes encountered in patients with
CRB1 mutations (Coppieters, et al., 2010; den Hollander, et al., 2004; den Hollander, et al.,
2001a; Henderson, et al., 2010; Yzer, et al., 2006b). Alternatively, these changes could be
related to abnormal laminar structure associated with CRB1-mutations (Jacobson, et al.,
2003). None of our patients developed Coats-like changes or para-arteriolar retinal pigment
epithelium suggesting that these changes are not consistant in CRB1-related RP (Lotery, et
al., 2001b). Four subjects displayed clumped retinopathies reinforcing that CRB1 should be
considered as a potential causal gene for this specific phenotype along with NR2E3 (Sharon,
et al., 2003) or NRL (Nishiguchi, et al., 2004).
CRB1 Variants and Their Classification
Over 240 patients with CRB1 mutations and more than 150 gene variants have been
described in the literature (Azam, et al., 2011; Benayoun, et al., 2009; Bernal, et al., 2003;
Booij, et al., 2005; Clark, et al., 2010; Coppieters, et al., 2010; den Hollander, et al., 2004;
den Hollander, et al., 2001a; den Hollander, et al., 2007; den Hollander, et al., 1999; Galvin,
et al., 2005; Gerber, et al., 2002; Hanein, et al., 2004; Henderson, et al., 2010; Henderson, et
al., 2007; Jacobson, et al., 2003; Khaliq, et al., 2003; Li, et al., 2011; Lotery, et al., 2001a;
Lotery, et al., 2001b; Riveiro-Alvarez, et al., 2008; Seong, et al., 2008; Siemiatkowska, et
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al., 2011; Simonelli, et al., 2007; Tosi, et al., 2009; Vallespin, et al., 2007; Yzer, et al.,
2006a; Yzer, et al., 2006b; Zenteno, et al., 2011; Zernant, et al., 2005). The most frequently
occurring of the known mutations is the p.Cys948Tyr in exon 9 (96 alleles reported, 24% of
known CRB1 mutations) (Bernal, et al., 2003; Booij, et al., 2005; Clark, et al., 2010;
Coppieters, et al., 2010; den Hollander, et al., 2004; den Hollander, et al., 2001a; den
Hollander, et al., 2007; den Hollander, et al., 1999; Galvin, et al., 2005; Hanein, et al., 2004;
Henderson, et al., 2010; Henderson, et al., 2007; Jacobson, et al., 2003; Lotery, et al., 2001a;
Riveiro-Alvarez, et al., 2008; Tosi, et al., 2009; Vallespin, et al., 2007; Yzer, et al., 2006a;
Zernant, et al., 2005). In general most of the mutations are in exons 9 (41%) and 7 (27%),
therefore as a screening strategy these exons can be tested in the first instance (Figure 1,
Supp. Table S1). Exons 7 and 9 encode second and third laminin AG-like domains
respectively, implying that these domains are particularly important for CRB1 function.
Missense mutations constitute 66% of all known mutations, the remaining being frameshift,
truncation and splice site mutations.
We have attempted to classify all the reported mutations in three groups: 1) likely
pathogenic, 2) unclassified variants, 3) unlikely pathogenic. This classification was based on
the genetic data available from the literature, amino acid conservation and bioinformatic
pathogenicity prediction tools (Supp. Tables S1-S3). An important criterion was the
presence of two mutant alleles and co-segregation in the family. Approximately 30% of
cases were reported with only one mutant allele, assuming that the second mutation is within
the intronic region. For these patients however, one cannot exclude the possibility that there
is another molecular cause of the pathology. The lack of the second mutant CRB1 allele is
sometimes explained by a digenic inheritance, however so far it has not been proven by co-
segregation analysis (Li, et al., 2011; Vallespin, et al., 2007).
Pathogenicity is easier to asses in deletions and frameshift variants than in the case of
missense changes, hence the importance of the bioinformatic analysis of the pathogenicity,
amino acid conservation and functional analysis of the variants. On this basis we have not
considered two changes identified in our cohort as pathogenic (p.Gly959Ser and
p.Ala1354Thr) (den Hollander, et al., 2004; den Hollander, et al., 2001a)). The respective
patients did not carry a second CRB1 mutation and we did not consider the p.Gly959Ser and
p.Ala1354Thr substitutions as likely pathogenic, based on poor conservation of the residues
and low pathogenicity predictions using online bioinformatic tools: PolyPhen-2 and SIFT
(Supp. Tables S2 and S3). One report suggests involvement of CRB1 in autosomal dominant
pigmented paravenous chorioretinal atrophy (McKay, et al., 2005), though the reported
mutation p.Val162Met has a questionable pathogenicity, since valine is not conserved and
methionine is present in this position in other mammals (Supp. Table S2).
Prevalence
In the investigated cohort, at least 2.5% of arRP patients carry CRB1 gene defects, which
lies within the previously published range of 0-6.5% (Bernal, et al., 2003; den Hollander, et
al., 2004; Vallespin, et al., 2007), or 2.7% after cohort averaging (Table 4). The high
preponderance of novel CRB1 mutations in our cohort suggests, however, that probably
more arRP patients carry CRB1 pathogenic defects, which are novel and therefore
undetectable by arRP microarray. Much higher prevalence is observed in LCA/EORD
cohorts and RP with additional features like PPRPE and retinal telangiectasia, representing
10.1%, 74.1%, 53.3% respectively in averaged cohorts (Table 4) (Bernal, et al., 2003;
Coppieters, et al., 2010; den Hollander, et al., 2004; den Hollander, et al., 2001a; den
Hollander, et al., 2007; den Hollander, et al., 1999; Hanein, et al., 2004; Henderson, et al.,
2010; Henderson, et al., 2007; Lotery, et al., 2001a; Seong, et al., 2008; Simonelli, et al.,
2007; Vallespin, et al., 2007; Walia, et al., 2010).
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Genotype-Phenotype Correlation
We were not able to establish a clear genotype/phenotype correlation for our cohort, which
might be due to the small number of patients with CRB1 mutations and their variable
phenotype. In addition, the nature of existing published data makes it difficult to correlate
the recurring CRB1 mutations with different phenotypes for a number of reasons. First, the
phenotyping of patients is complex and distinguishing between early-onset RP and LCA is
often arbitrary and depends on the guidelines of a particular clinical center. Second, precise
clinical data is often omitted in the publications and therefore it is difficult to adjust for these
diagnostic differences in a cross-paper analysis. Despite these inconsistencies, we attempted
to analyse data from previous reports in order to find the relationship between the CRB1
variants and the clinical features of respective patients. In this meta-analysis we used 171
patients, who carried two likely pathogenic mutations in trans (Benayoun, et al., 2009;
Bernal, et al., 2003; Booij, et al., 2005; Clark, et al., 2010; Coppieters, et al., 2010; den
Hollander, et al., 2004; den Hollander, et al., 2001a; den Hollander, et al., 2007; den
Hollander, et al., 1999; Galvin, et al., 2005; Hanein, et al., 2004; Henderson, et al., 2010;
Henderson, et al., 2007; Jacobson, et al., 2003; Khaliq, et al., 2003; Li, et al., 2011; Lotery,
et al., 2001a; Lotery, et al., 2001b; McKibbin, et al., 2010; Riveiro-Alvarez, et al., 2008;
Seong, et al., 2008; Simonelli, et al., 2007; Tosi, et al., 2009; Vallespin, et al., 2007; Yzer, et
al., 2006a). Combination of two mutant alleles was analysed in relation to clinical
characteristics of the published cases. Based on the reports we distinguished the following
phenotypes: LCA, early onset retinal degeneration (EORD), RP, presence of PPRPE and
Coats-like vasculopathy. The mutations were classed as null mutations (all mutations
leading to a premature stop codon) or as variants leading to an altered protein (missense and
in frame deletions). The likely pathogenic mutations were plotted on a graph, where affected
codons on allele 1 and allele 2 served as coordinates (codon 0 was assigned to null
mutations). The results show that we cannot assign a specific allele combination to a
particular phenotype, e.g. homozygous null alleles or homozygous p.Cys948Tyr alleles are
found in LCA, EORD and RP patients (Figure 3 A). Null alleles are however more frequent
in LCA cohorts (Figure 3 B) as previously suggested (den Hollander, et al., 2004). The
presence/absence of PPRPE or Coats-like vasculopathy did not reveal a particular mutation
pattern (Figure 3 C). These findings suggest the involvement of additional modifying factors
(genetic and/or environmental), which are responsible for the modulation of the phenotype
in patients harboring CRB1 mutations.
Future Directions
The above analysis of the phenotype-genotype correlation suggests that the disease
severities associated with CRB1 mutations are in fact a continuum of the same clinical entity
with possible additional modifying factors influencing disease onset and progression. There
is increasing evidence of the involvement of multiple alleles in the patient’s phenotype, as
has been shown for the Bardet-Biedl patients (Katsanis, et al., 2001) and more recently for a
PRPH2-associated macular dystrophy family, where the phenotype has been modulated by
additional heterozygous mutations in ABCA4 (MIM# 601691) and ROM1 (MIM# 180721)
(Poloschek, et al., 2010). It is likely that the new next generation sequencing (NGS)
technology will help to shed light on the potential genetic modifiers that influence disease
phenotype. One has, however, to analyse the data with caution since NGS will reveal large
numbers of polymorphic changes, which do not modulate the disease. The potential new
modifying changes will have to be confirmed by appropriate genetic and functional analysis.
The certainty of the molecular cause of a disease is particularly important in the era of gene
therapy trials. Genetic treatment of recessive disorders should not be undertaken before
obtaining proof that both alleles of a given gene are dysfunctional. In-depth genetic analysis,
as presented here, is necessary to provide a basis for conducting such therapies.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Distribution of CRB1 mutations in the gene and protein. A) Nucleotide numbering is based
on cDNA sequence of CRB1 (Ref. NM_201253.2) where A of the ATG initiation codon is
1. The stop and frameshift mutations are indicated above the structure of the gene and the
position of the missense mutations are drawn in relation to protein domains. The novel
mutations are indicated in red. B) The structures of EGF-like and Ca++ binding EGF-like
domains with indications of conserved residues and recurrent mutations. The highly
conserved cysteine residues are in black, the conserved residues between both domains are
in grey and the conserved amino acids specific to the Ca2+ binding domain are in blue. C)
Evolutionary conservation of the likely pathogenic CRB1 residue changes identified in this
work.
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Figure 2.
Fundus color photographs and Optical Coherence Tomography (OCT). A) Color fundus
photograph of the left eye of 3969 showing nummular pigmentary migration in the mid
periphery in addition to pigmentary changes within the macula. B) Vertical scan OCT of the
left eye of 3969 showing cystic changes in the macular region. C) Color fundus photograph
of the right eye of 547 showing bone spicules pigmentary migration in the periphery in
addition to atrophic changes within the macula. D) Vertical scan OCT of the right eye of 547
showing atrophic changes in the macular region after resolution of episodes of cystoid
changes.
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Figure 3.
Genotype-phenotype correlation of patients with CRB1 mutations. A) Distribution of CRB1
mutations in LCA, EORD and RP. XY axes represent allele 1 and 2 of the patients, the
affected codons serve as xy coordinates, null allele coordinate is designated as 0. The size of
the circles is proportional to the number of the CRB1 patients with a given genotype. B)
Frequency of null and missense allele combinations in LCA, EORD and RP patients. C)
Distribution of CRB1 mutations in patients with/without additional features: PPRPE and
Coats-like vasculopathy.
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Table 3
Function data
Patient Colour vision(15 saturated Hue)
Binocular Goldman visual field, III4
isopter Full field ERG Multifocal ERG
53 NP Inf to 5° ND ND
54 Dyschromatopsiawithout axis Inf to 5° ND ND
229 Normal
40 central degree with 2 peripheral
island
of perception
ND ND
368 Normal 120° horizontally, 60° vertically withrelative central annular scotoma
Residual responses consistent with
severe rod-
cone dysfunction
Residual responses to
central hexagones
409 Dyschromatopsiawithout axis
100° horizontally, 60° vertically with
annular scotoma Residual cone responses ND
547 Bilateral tritaonopia
20 central degrees both horizontally
and
vertically
ND ND
1183 NP Inf to 5° ND ND
1731 OD NP, OS tritaonopia 5 central degrees ND ND
03144 Normal
20 central degrees both horizontally
and
vertically
ND ND
3969 Dyschromatopsiawithout axis
20 central degree with 2 peripheral
island
of perception
ND ND
4240 Normal 130° vertically and 110° horizontally
30% decreased scotopic responses
with photopic
responses at the lower limit of
normal
Decreased responses to
central hexagones
NP: not performed; ND: not detectable
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